止痛药市场规模、份额和成长分析（按药物类型、给药途径、应用、分销管道和地区划分）—产业预测，2026-2033年

2024 年止痛药市场规模为 433.8 亿美元，预计从 2025 年的 460 亿美元成长到 2033 年的 734.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 6.02%。

全球止痛药市场正经历稳定成长，主要受以下几个关键因素驱动：慢性疼痛疾病盛行率的上升和人口老化是推动市场需求的主要因素，同时人们对有效疼痛管理策略的认识也不断提高。处方笺和非处方止痛药因其缓解疼痛的有效性而备受青睐。此外，药物输送系统的进步、创新止痛药配方的推出以及强大的学名药研发管线也进一步推动了市场扩张。主要企业之间的策略联盟和併购也发挥关键作用，增强了产品系列，并扩大了其在全球止痛药市场的份额。这种动态的市场格局反映了全球止痛解决方案日益增长的重要性。

止痛药市场驱动因素

全球止痛药市场的成长主要受慢性疼痛疾病发生率上升的推动。这些疾病影响着很大一部分人口，导致对有效止痛方案的需求不断增长。关节炎、癌症、神经病变疼痛和肌肉骨骼疾病等都加剧了这一负担。因此，人们迫切需要能够缓解疼痛并改善患者生活品质的止痛药物。此外，人们对疼痛管理重要性的认识不断提高，加上药物研发的进步，正在推动新型和改良止痛药物的创新和开发，进一步促进市场扩张。

止痛药市场的限制

全球止痛药市场面临的一大挑战是某些止痛药（尤其是鸦片类药物）的副作用风险和潜在滥用问题。这些鸦片类药物与成瘾、成瘾和过量用药等问题密切相关，引发了严重的公共卫生担忧。这导致监管审查力道加大，处方规范也更加严格。因此，医疗专业人员在开立鸦片类止痛药时越来越谨慎，并鼓励转向非鸦片类替代药物和替代性疼痛管理方法。如何在有效缓解疼痛和降低滥用风险之间取得平衡，是限制市场成长的一大障碍。

止痛药市场趋势

塑造全球止痛药市场的关键趋势是，由于人们对鸦片类药物使用风险（包括成瘾和过量服用风险）的认识不断提高，非鸦片类止痛药的需求日益增长。随着医护人员和患者寻求更安全的疼痛管理方案，他们开始转向非阿片类替代药物，例如非类固醇消炎剂(NSAIDs) 和乙酰胺酚，这些药物已被证明能有效缓解轻度至中度疼痛。这一转变反映了人们越来越倾向于负责任的疼痛管理实践，并推动了以安全性和有效性为优先的新型疗法的研发创新。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 专利分析
• 案例研究
• Start-Ups分析

全球止痛药市场规模（按药物类型和复合年增长率划分）（2026-2033 年）

• 阿片类止痛药
  • 氢可酮
  • Fentanyl
  • 羟考酮
  • 氢可酮
• 非鸦片类止痛药
  • 非类固醇消炎剂（NSAIDs）
  • Ibuprofen
  • 萘普生
  • 阿斯匹灵
  • 乙酰胺酚
  • 复方镇痛药

全球止痛药市场规模（依给药途径及复合年增长率划分）（2026-2033 年）

• 口服
  • 药片
  • 胶囊
  • 液体
• 局部的
  • 奶油
  • 凝胶
  • 修补
• 注射
  • 静脉注射
  • 肌肉内注射
• 经皮吸收型

全球止痛药市场规模（按应用和复合年增长率划分）（2026-2033 年）

• 慢性疼痛
  • 关节炎
  • 癌症疼痛
  • 神经病变疼痛
• 急性疼痛
  • 术后疼痛
  • 创伤性疼痛
• 其他的
  • 偏头痛
  • 纤维肌痛

全球止痛药市场规模（按分销管道和复合年增长率划分）（2026-2033 年）

• 医院药房
• 零售药房
• 网路药房

全球止痛药市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2021-2023年营收年比比较

主要企业简介

• Pfizer Inc.
• Johnson & Johnson
• GlaxoSmithKline plc（GSK）
• Sanofi SA
• Bayer AG
• Novartis AG
• Merck & Co., Inc.
• AstraZeneca PLC
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Endo Pharmaceuticals Inc.
• Purdue Pharma LP
• Mallinckrodt Pharmaceuticals
• Horizon Therapeutics plc
• Sun Pharmaceutical Industries Ltd.
• Dr. Reddy's Laboratories Ltd.
• Zydus Cadila

结论与建议

Analgesics Market size was valued at USD 43.38 Billion in 2024 and is poised to grow from USD 46 Billion in 2025 to USD 73.42 Billion by 2033, growing at a CAGR of 6.02% during the forecast period (2026-2033).

The global analgesics market is experiencing consistent growth, fueled by several key factors. A rising prevalence of chronic pain conditions and an increasing geriatric population are significantly driving demand, alongside a heightened awareness of effective pain management strategies. Both prescription and over-the-counter analgesics are witnessing heightened demand due to their effectiveness in alleviating discomfort. Moreover, advancements in drug delivery systems and the introduction of innovative analgesic formulations, alongside a robust pipeline of generic options, are propelling further market expansion. Strategic collaborations and mergers among major players also play a crucial role, enhancing product portfolios and broadening their global presence in the analgesics landscape. This dynamic landscape reflects the increasing prioritization of pain relief solutions worldwide.

Top-down and bottom-up approaches were used to estimate and validate the size of the Analgesics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Analgesics Market Segments Analysis

Global Analgesics Market is segmented by drug type, route of administration, application, distribution channel and region. Based on drug type, the market is segmented into opioid analgesics and non-opioid analgesics. Based on route of administration, the market is segmented into oral, topical, injectable and transdermal. Based on application, the market is segmented into chronic pain, acute pain and other. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Analgesics Market

The global analgesics market is significantly driven by the rising incidence of chronic pain conditions, which impact a large segment of the population and create an increasing demand for effective pain relief solutions. Conditions such as arthritis, cancer, neuropathic pain, and musculoskeletal disorders all contribute to this escalating burden. Consequently, there is a pressing need for analgesic medications that can alleviate pain and enhance patients' quality of life. Additionally, the growing awareness regarding the importance of pain management, combined with advancements in pharmaceutical research, stimulates the innovation and development of new and improved analgesic drugs, further propelling market expansion.

Restraints in the Analgesics Market

A major challenge faced by the global analgesics market is the risk of side effects and the potential for misuse associated with certain analgesic medications, particularly opioids. These opioid-based drugs are linked to issues such as dependence, addiction, and overdose, raising serious public health concerns. This has resulted in heightened scrutiny from regulatory bodies and the establishment of more stringent prescription practices. As a consequence, healthcare providers are becoming increasingly cautious when it comes to prescribing opioid analgesics, which is fueling a transition towards non-opioid alternatives and different pain management methods. Balancing the demand for effective pain relief while reducing the risk of abuse presents a significant obstacle to market growth.

Market Trends of the Analgesics Market

A significant trend shaping the global analgesics market is the rising preference for non-opioid analgesics driven by heightened awareness of the dangers associated with opioid use, including addiction and overdose risks. As healthcare professionals and patients alike seek safer pain management options, there is an increasing focus on utilizing non-opioid alternatives such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, which are proving effective for alleviating mild to moderate pain. This shift reflects a broader movement towards responsible pain management practices and is fostering innovation in the development of new therapeutic agents that prioritize safety and efficacy.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies
• Startup Analysis

Global Analgesics Market Size by Drug Type & CAGR (2026-2033)

• Market Overview
• Opioid Analgesics
  • Morphine
  • Fentanyl
  • Oxycodone
  • Hydrocodone
• Non-Opioid Analgesics
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Ibuprofen
  • Naproxen
  • Aspirin
  • Acetaminophen
  • Compound Analgesics

Global Analgesics Market Size by Route Of Administration & CAGR (2026-2033)

• Market Overview
• Oral
  • Tablets
  • Capsules
  • Liquids
• Topical
  • Creams
  • Gels
  • Patches
• Injectable
  • Intravenous
  • Intramuscular
• Transdermal

Global Analgesics Market Size by Application & CAGR (2026-2033)

• Market Overview
• Chronic Pain
  • Arthritis
  • Cancer Pain
  • Neuropathic Pain
• Acute Pain
  • Postoperative Pain
  • Injury Pain
• Other
  • Migraine
  • Fibromyalgia

Global Analgesics Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Analgesics Market Size & CAGR (2026-2033)

• North America (Drug Type, Route Of Administration, Application, Distribution Channel)
  • USA
  • Canada
• Europe (Drug Type, Route Of Administration, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Drug Type, Route Of Administration, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Drug Type, Route Of Administration, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Drug Type, Route Of Administration, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline plc (GSK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol-Myers Squibb Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Purdue Pharma L.P.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mallinckrodt Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Horizon Therapeutics plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Cadila
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations